Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Federico

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|March 27, 2025
Towards P2X4 Positron Emission Tomography TracingStephanie Federico
Expert Opinion on Therapeutic Patents|March 23, 2012
Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligandsStephanie Federico, Giampiero Spalluto
Future Medicinal Chemistry|July 19, 2019
Functionalized ligands targeting G protein-coupled adenosine receptorsStephanie Federico, Giampiero Spalluto
Current Medicinal Chemistry|August 17, 2022
Promising Targets and Strategies to Control Neuroinflammation (Part II)Stephanie Federico, Stefano Moro
Current Medicinal Chemistry|August 17, 2022
Promising Targets and Strategies to Control Neuroinflammation (Part I)Stephanie Federico, Stefano Moro
Mini Reviews in Medicinal Chemistry|April 26, 2018
A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?Barbara Cacciari, Giampiero Spalluto, Stephanie Federico
Pharmaceuticals (Basel, Switzerland)|November 16, 2019
Chemical Probes for the Adenosine ReceptorsStephanie Federico, Lucia Lassiani, Giampiero Spalluto
Methods in Enzymology|November 6, 2010
Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agentsSilvia Paoletta, Stephanie Federico, Giampiero Spalluto, et al.
Current Pharmaceutical Design|December 24, 2009
Human A3 adenosine receptor as versatile G protein-coupled receptor example to validate the receptor homology modeling technologyErika Morizzo, Stephanie Federico, Giampiero Spalluto, et al.
Cells|October 28, 2025
Adenosine Receptors in Neuroinflammation and NeurodegenerationVeronica Salmaso, Silvia Menin, Stefano Moro, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|March 27, 2025
Towards P2X4 Positron Emission Tomography TracingStephanie Federico
Expert Opinion on Therapeutic Patents|March 23, 2012
Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligandsStephanie Federico, Giampiero Spalluto
Future Medicinal Chemistry|July 19, 2019
Functionalized ligands targeting G protein-coupled adenosine receptorsStephanie Federico, Giampiero Spalluto
Current Medicinal Chemistry|August 17, 2022
Promising Targets and Strategies to Control Neuroinflammation (Part II)Stephanie Federico, Stefano Moro
Current Medicinal Chemistry|August 17, 2022
Promising Targets and Strategies to Control Neuroinflammation (Part I)Stephanie Federico, Stefano Moro
Mini Reviews in Medicinal Chemistry|April 26, 2018
A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?Barbara Cacciari, Giampiero Spalluto, Stephanie Federico
Pharmaceuticals (Basel, Switzerland)|November 16, 2019
Chemical Probes for the Adenosine ReceptorsStephanie Federico, Lucia Lassiani, Giampiero Spalluto
Methods in Enzymology|November 6, 2010
Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agentsSilvia Paoletta, Stephanie Federico, Giampiero Spalluto, et al.
Current Pharmaceutical Design|December 24, 2009
Human A3 adenosine receptor as versatile G protein-coupled receptor example to validate the receptor homology modeling technologyErika Morizzo, Stephanie Federico, Giampiero Spalluto, et al.
Cells|October 28, 2025
Adenosine Receptors in Neuroinflammation and NeurodegenerationVeronica Salmaso, Silvia Menin, Stefano Moro, et al.
Pageof 6